⌘K

Login Start Free

Tonix Pharmaceuticals Holding Corp.·4

Mar 28, 8:00 AM ET

LEDERMAN SETH 4

4 · Tonix Pharmaceuticals Holding Corp. · Filed Mar 28, 2022

Insider Transaction Report

Form 4

Period: 2022-03-25

Tonix Pharmaceuticals Holding Corp.TNXP

DirectorChief Executive Officer

Transactions

Purchase
Common Stock, $0.001 par value
2022-03-25$0.24/sh+100,000$24,500→ 112,177 total

Holdings

Common Stock, $0.001 par value
(indirect: By IRA)
459
Common Stock, $0.001 par value
(indirect: By Starling Pharmaceuticals, Inc.)
30
Common Stock, $0.001 par value
(indirect: By 401(k))
135,000
Common Stock, $0.001 par value
(indirect: By LLC)
205
Common Stock, $0.001 par value
(indirect: By LLC)
33
Common Stock, $0.001 par value
(indirect: By Leder Laboratories, Inc.)
30
Common Stock, $0.001 par value
(indirect: By LLC)
59
Common Stock, $0.001 par value
(indirect: By Spouse)
31

Footnotes (1)

[F1]Reporting person may be deemed to be a control person of this entity.

Documents

1 file

4
lederman-form4_032522.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP